{"id":"https://openalex.org/W2553970103","doi":"https://doi.org/10.1183/13993003.congress-2016.pa4122","title":"P-PiXel: A 'real-life' evaluation of omalizumab use in asthmatic patients","display_name":"P-PiXel: A 'real-life' evaluation of omalizumab use in asthmatic patients","publication_year":2016,"publication_date":"2016-09-01","ids":{"openalex":"https://openalex.org/W2553970103","doi":"https://doi.org/10.1183/13993003.congress-2016.pa4122","mag":"2553970103"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2016.pa4122","doi":"https://doi.org/10.1183/13993003.congress-2016.pa4122","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2016.pa4122","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"5.1 Airway Pharmacology and Treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036601889","display_name":"Alain Michils","orcid":"https://orcid.org/0000-0002-0464-7472","observed_orcids":["https://orcid.org/0000-0002-0464-7472"]},"institutions":[{"id":"https://openalex.org/I2802054198","display_name":"Erasmus Hospital","ror":"https://ror.org/05j1gs298","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2802054198"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Alain Michils","raw_affiliation_strings":["Pneumologie, H\u00f4pital Erasme"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pneumologie, H\u00f4pital Erasme","institution_ids":["https://openalex.org/I2802054198"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059141841","display_name":"Antoine Poskin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Antoine Poskin","raw_affiliation_strings":["Therapeutic Area Respiratory, Novartis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therapeutic Area Respiratory, Novartis","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071183245","display_name":"Jan Van Schoor","orcid":"https://orcid.org/0000-0002-6674-8316","observed_orcids":["https://orcid.org/0000-0002-6674-8316"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jan Van Schoor","raw_affiliation_strings":["Therapeutic Area Respiratory, Novartis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therapeutic Area Respiratory, Novartis","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068493725","display_name":"Stefaan Vancayzeele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Stefaan Vancayzeele","raw_affiliation_strings":["Therapeutic Area Respiratory, Novartis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therapeutic Area Respiratory, Novartis","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001199263","display_name":"Sandra Gurdain","orcid":"https://orcid.org/0000-0002-7235-687X","observed_orcids":["https://orcid.org/0000-0002-7235-687X"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sandra Gurdain","raw_affiliation_strings":["Therapeutic Area Respiratory, Novartis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therapeutic Area Respiratory, Novartis","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038241334","display_name":"Muriel Lins","orcid":"https://orcid.org/0009-0006-0989-4268","observed_orcids":["https://orcid.org/0009-0006-0989-4268"]},"institutions":[{"id":"https://openalex.org/I4405284891","display_name":"AZ Sint-Maarten","ror":"https://ror.org/04crz8262","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4405284891"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Muriel Lins","raw_affiliation_strings":["Pneumologie, AZ Sint-Maarten"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pneumologie, AZ Sint-Maarten","institution_ids":["https://openalex.org/I4405284891"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA4122","last_page":"PA4122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":1.0},{"id":"https://openalex.org/keywords/anti-ige-monoclonal-antibody","display_name":"anti-IgE monoclonal antibody","score":0.9200000166893005},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.8629999756813049},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.8629999756813049},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.703000009059906},{"id":"https://openalex.org/keywords/asthma-related-quality-of-life","display_name":"asthma quality of life","score":0.796999990940094},{"id":"https://openalex.org/keywords/severe-asthma-exacerbation","display_name":"severe asthma exacerbation","score":0.765999972820282},{"id":"https://openalex.org/keywords/oral-corticosteroid-dose-reduction","display_name":"oral corticosteroid reduction","score":0.8740000128746033},{"id":"https://openalex.org/keywords/long-term-maintenance-therapy","display_name":"long-term maintenance therapy","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9515562057495117},{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.915561854839325},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.7633563280105591},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.6572181582450867},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.6144100427627563},{"id":"https://openalex.org/C2909082789","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma exacerbations","level":3,"score":0.4804777204990387},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.4602462649345398},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.45293548703193665},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.45050644874572754},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4393230676651001},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4111538231372833},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.27276039123535156},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.18427228927612305},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.17062050104141235},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1218307614326477},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1183/13993003.congress-2016.pa4122","doi":"https://doi.org/10.1183/13993003.congress-2016.pa4122","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2016.pa4122","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"5.1 Airway Pharmacology and Treatment","raw_type":"proceedings-article"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/261128","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/261128","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/conferenceContribution"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/261129","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/261129","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The European respiratory journal, 48 (S60","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1910127135","https://openalex.org/W2099211356","https://openalex.org/W7100659555","https://openalex.org/W2548196387","https://openalex.org/W2125119017","https://openalex.org/W2557000371","https://openalex.org/W1855387916","https://openalex.org/W2042255056","https://openalex.org/W3006418623","https://openalex.org/W2991546823"],"abstract_inverted_index":{"Omalizumab":[0],"(OMA)":[1],"(Xolair\u00ae)":[2],"is":[3],"an":[4,110],"anti-IgE":[5],"monoclonal":[6],"antibody":[7],"indicated":[8],"for":[9,27,68],"the":[10,34,73,77,81,126,168],"maintenance":[11],"treatment":[12,20,152,252],"of":[13,37,101,112,125,243],"persistent":[14,150],"severe":[15,113],"allergic":[16],"asthma":[17,99],"(PSAA).":[18],"OMA":[19,38,82,86,132,205,251,268],"requires":[21],"(once/twice)":[22],"monthly":[23],"injections":[24],"causing":[25],"concerns":[26],"persistence":[28,74,247,264],"and":[29,80,146,158,177,189,223,231,248,259,265],"adherence":[30,79,249],"to":[31,71,75,131,151,182,196,250],"treatment;":[32],"hereto,":[33],"long-term":[35,263],"use":[36],"was":[39,49,88,206,216],"studied":[40],"in":[41,54,98,118,208,255,274],"a":[42,91,116],"real-life":[43],"setting.":[44],"A":[45],"prospective":[46],"observational":[47],"study":[48],"conducted":[50],"over":[51,271],"120":[52,272],"weeks":[53,273],"50":[55],"PSAA":[56,244],"patients":[57,127,210,260],"treated":[58],"with":[59],"OMA.":[60],"As":[61],"from":[62,95,163,167,193,202,236],"week":[63,96,134,154,185,194,197,212,227],"16":[64,195],"(evaluation":[65],"time":[66],"point":[67,94],"clinical":[69],"response":[70],"OMA),":[72],"treatment,":[76],"appointment":[78,183],"effectiveness":[83,87,270],"were":[84,129,149,180,253],"evaluated.":[85],"defined":[89],"as":[90,267],"change":[92],"\u22650.5":[93],"0":[97],"quality":[100],"life":[102],"questionnaire":[103],"(AQLQ)":[104],"total":[105],"score":[106],"(or":[107],"sub-score);":[108],"and/or":[109,115],"absence":[111],"exacerbation;":[114],"reduction":[117],"oral":[119],"corticosteroid":[120],"use.":[121],"At":[122],"least":[123],"92%":[124],"(46/50)":[128],"responders":[130],"at":[133,153,184,211,226],"16.":[135],"From":[136],"these":[137],"46":[138,169],"responders,":[139,170],"39":[140],"(85%),":[141],"33":[142],"(72%),":[143],"31":[144,209],"(67%)":[145],"30":[147],"(65%)":[148],"52,":[155,186,198,228],"68,":[156,187,229],"104":[157,188,230],"120,":[159,190,232],"respectively":[160,191,233],"(all":[161,234],"p":[162,201,235],"visit-to-visit":[164,203,237],"<0.05).":[165,204],"Also,":[166],"41":[171],"(89%),":[172],"32":[173],"(70%),":[174],"29":[175,219],"(63%)":[176],"26":[178],"(57%)":[179],"adherent":[181],"(p>0.05":[192],"then":[199],"all":[200],"effective":[207],"16,":[213],"while":[214],"this":[215,240],"28":[217],"(90%),":[218],"(94%),":[220],"25":[221],"(81%)":[222],"24":[224],"(77%)":[225],">0.05).":[238],"In":[239],"limited":[241],"cohort":[242],"patients,":[245],"initial":[246],"high":[254],"real-life.":[256],"Subsequently,":[257],"physicians":[258],"must":[261],"optimize":[262],"adherence,":[266],"proved":[269],"most":[275],"patients.":[276]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-11-30T00:00:00"}